Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-11

Clinical Trial Update: Introduction of Hypo-osmolar ORS for Routine Use [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update introducing hypo-osmolar oral rehydration solution (ORS) for routine use in diarrhoea management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypo-osmolar oral rehydration solution (ORS)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Diarrhoea | Phase 4 | Status: COMPLETED